269 related articles for article (PubMed ID: 17805238)
1. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer.
Russo D; Miranda I; Ruocco C; Battaglia Y; Buonanno E; Manzi S; Russo L; Scafarto A; Andreucci VE
Kidney Int; 2007 Nov; 72(10):1255-61. PubMed ID: 17805238
[TBL] [Abstract][Full Text] [Related]
2. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.
Kakuta T; Tanaka R; Hyodo T; Suzuki H; Kanai G; Nagaoka M; Takahashi H; Hirawa N; Oogushi Y; Miyata T; Kobayashi H; Fukagawa M; Saito A
Am J Kidney Dis; 2011 Mar; 57(3):422-31. PubMed ID: 21239096
[TBL] [Abstract][Full Text] [Related]
3. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
Takei T; Otsubo S; Uchida K; Matsugami K; Mimuro T; Kabaya T; Akiba T; Nitta K
Nephron Clin Pract; 2008; 108(4):c278-83. PubMed ID: 18434749
[TBL] [Abstract][Full Text] [Related]
4. Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial.
Di Iorio B; Molony D; Bell C; Cucciniello E; Bellizzi V; Russo D; Bellasi A;
Am J Kidney Dis; 2013 Oct; 62(4):771-8. PubMed ID: 23684755
[TBL] [Abstract][Full Text] [Related]
5. Long-term comparison of a calcium-free phosphate binder and calcium carbonate--phosphorus metabolism and cardiovascular calcification.
Braun J; Asmus HG; Holzer H; Brunkhorst R; Krause R; Schulz W; Neumayer HH; Raggi P; Bommer J
Clin Nephrol; 2004 Aug; 62(2):104-15. PubMed ID: 15356967
[TBL] [Abstract][Full Text] [Related]
6. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.
Block GA; Spiegel DM; Ehrlich J; Mehta R; Lindbergh J; Dreisbach A; Raggi P
Kidney Int; 2005 Oct; 68(4):1815-24. PubMed ID: 16164659
[TBL] [Abstract][Full Text] [Related]
7. Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
Raggi P; Bommer J; Chertow GM
J Heart Valve Dis; 2004 Jan; 13(1):134-41. PubMed ID: 14765851
[TBL] [Abstract][Full Text] [Related]
8. Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.
Galassi A; Spiegel DM; Bellasi A; Block GA; Raggi P
Nephrol Dial Transplant; 2006 Nov; 21(11):3215-22. PubMed ID: 16877490
[TBL] [Abstract][Full Text] [Related]
9. Switching from calcium carbonate to sevelamer hydrochloride has suppressive effects on the progression of aortic calcification in hemodialysis patients: assessment using plain chest X-ray films.
Izumi M; Morita S; Nishian Y; Miyamoto T; Kasumoto H; Oue M; Hori K; Kitamura R; Yamamoto S; Nakanishi T
Ren Fail; 2008; 30(10):952-8. PubMed ID: 19016145
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
Mason MA; Shepler BM
Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
[TBL] [Abstract][Full Text] [Related]
11. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
[TBL] [Abstract][Full Text] [Related]
12. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.
Block GA; Raggi P; Bellasi A; Kooienga L; Spiegel DM
Kidney Int; 2007 Mar; 71(5):438-41. PubMed ID: 17200680
[TBL] [Abstract][Full Text] [Related]
13. Mortality in kidney disease patients treated with phosphate binders: a randomized study.
Di Iorio B; Bellasi A; Russo D;
Clin J Am Soc Nephrol; 2012 Mar; 7(3):487-93. PubMed ID: 22241819
[TBL] [Abstract][Full Text] [Related]
14. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density.
Asmus HG; Braun J; Krause R; Brunkhorst R; Holzer H; Schulz W; Neumayer HH; Raggi P; Bommer J
Nephrol Dial Transplant; 2005 Aug; 20(8):1653-61. PubMed ID: 15930018
[TBL] [Abstract][Full Text] [Related]
15. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
Qunibi W; Moustafa M; Muenz LR; He DY; Kessler PD; Diaz-Buxo JA; Budoff M;
Am J Kidney Dis; 2008 Jun; 51(6):952-65. PubMed ID: 18423809
[TBL] [Abstract][Full Text] [Related]
16. Determinants of progressive vascular calcification in haemodialysis patients.
Chertow GM; Raggi P; Chasan-Taber S; Bommer J; Holzer H; Burke SK
Nephrol Dial Transplant; 2004 Jun; 19(6):1489-96. PubMed ID: 15102961
[TBL] [Abstract][Full Text] [Related]
17. Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study.
Lemos MM; Watanabe R; Carvalho AB; Jancikic AD; Sanches FM; Christofalo DM; Draibe SA; Canziani ME
Clin Nephrol; 2013 Jul; 80(1):1-8. PubMed ID: 23442255
[TBL] [Abstract][Full Text] [Related]
18. Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Itoh K; Tanaka M; Hashiguchi J; Funakoshi S; Nakano H; Kubo H; Kono T; Uchino J; Masaki K; Date T; Shigematsu T;
Ther Apher Dial; 2008 Apr; 12(2):126-32. PubMed ID: 18387160
[TBL] [Abstract][Full Text] [Related]
19. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
Cozzolino M; Dusso AS; Liapis H; Finch J; Lu Y; Burke SK; Slatopolsky E
J Am Soc Nephrol; 2002 Sep; 13(9):2299-308. PubMed ID: 12191974
[TBL] [Abstract][Full Text] [Related]
20. Sevelamer therapy for pediatric end-stage renal disease.
Storms LE; Chicella MF; Dice JE
Pharmacotherapy; 2006 Mar; 26(3):410-3. PubMed ID: 16503722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
